BiVACOR's Total Artificial Heart Receives FDA Breakthrough Device Designation
HUNTINGTON BEACH, Calif., May 30, 2025--(BUSINESS WIRE)--BiVACOR, a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
The designation supports the BiVACOR TAH as a bridge to transplant (BTT) for adults with severe biventricular or univentricular heart failure where current treatments, including LVADs, are not viable. The FDA's Breakthrough Device program is reserved for technologies that may significantly improve outcomes for patients with life-threatening or irreversibly debilitating conditions. It offers priority regulatory interaction and accelerated pathways to approval.
"This is more than a regulatory milestone. It's a validation of a concept we've spent decades proving that a fully implantable, total artificial heart isn't just possible, it's necessary," said Daniel Timms, PhD, Founder and Chief Technology Officer of BiVACOR. "Patients with biventricular failure have been overlooked for too long. The early results from our clinical trial show that we can give them a second chance, without the compromises of older technologies. The Breakthrough Device Designation puts us on a faster track to deliver exactly that."
The milestone follows the first phase of BiVACOR's FDA Early Feasibility Study, where five patients in the U.S. received the TAH between July and November 2024. Based on positive safety and performance data, the FDA approved the expansion of the trial to include 15 additional patients starting later this year.
BiVACOR's device represents a new category in artificial heart technology. Compact enough to fit most men and women, the TAH uses magnetic levitation, similar to maglev trains, to suspend a single dual-sided rotor. This rotor simultaneously powers the right and left circulatory systems, mimicking the natural heartbeat without valves or mechanical wear points. Its simplified design allows for pulsatile flow, large blood gaps to reduce trauma, and long-term durability.
"We've seen every kind of artificial heart technology over the last four decades, but this is the first system I've encountered that combines engineering elegance, efficiency, and safety with true clinical viability," said William Cohn, MD, BiVACOR Chief Medical Officer and heart surgeon at the Texas Heart Institute. "The early results are remarkable with no strokes, no device-related complications, and a safety profile unlike anything in this space. With Breakthrough status in hand, we're entering the next phase with the wind at our backs and real momentum to bring this to more patients."
Heart failure affects more than 6 million Americans, and thousands of patients each year progress to irreversible biventricular failure. However, the number of available donor hearts remains stagnant, with fewer than 4,500 transplants performed annually in the U.S. BiVACOR is targeting this critical gap with a durable artificial replacement engineered for eventual long-term support.
The BiVACOR TAH is currently investigational and not approved for commercial use.
About BiVACOR
BiVACOR® is a clinical-stage medical device company developing a fully implantable, magnetically levitated Total Artificial Heart for long-term support of patients with end-stage biventricular heart failure. Founded by biomedical engineer Daniel Timms, PhD, and backed by leading experts in cardiovascular medicine including Dr. William E. Cohn and Dr. O.H. (Bud) Frazier, the company is conducting an FDA-approved Early Feasibility Study in the U.S. Headquartered in Huntington Beach, CA, with clinical operations in Houston and engineering offices in Gold Coast, Australia, BiVACOR is committed to addressing the global shortage of donor hearts through advanced, scalable technology. Learn more at www.bivacor.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529170802/en/
Contacts
Media Contact: Dana SummersPenman PRdana@penmanpr.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
26 minutes ago
- Business Wire
Mogo Repurchases 2% of Outstanding Shares in Q2 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--Mogo Inc. ('Mogo' or the 'Company') (NASDAQ: MOGO; TSX: MOGO), a Canadian financial technology company offering solutions across wealth, lending, and payments, today announced that it repurchased approximately 2% of its currently issued and outstanding shares during the second quarter of 2025 under its previously announced NASDAQ buyback program. During the quarter, the Company repurchased 523,091 common shares at an average price of approximately US$1.44 per share. The shares were purchased for cancellation, reducing the total number of shares outstanding to approximately 24 million as of June 30, 2025. 'This repurchase activity reflects our continued commitment to disciplined capital allocation and long-term shareholder value,' said Greg Feller, President & Co-Founder. 'We view share buybacks as a strategic use of capital when we believe our stock is trading meaningfully below intrinsic value.' Bitcoin Hurdle Rate Now Guides Capital Deployment In alignment with the Company's recently announced Bitcoin treasury strategy, all future capital allocation decisions, including share repurchases, will be evaluated against a Bitcoin hurdle rate. Under this framework, capital will only be deployed into opportunities expected to outperform the long-term return profile of holding Bitcoin. 'If we believe repurchasing our shares offers greater long-term value than holding Bitcoin, we will act accordingly,' added Greg Feller. 'If not, we will preserve capital or continue building our Bitcoin reserve.' Remaining Authorization As of July 1, 2025, Mogo has approximately US$7 million in remaining repurchase capacity under its share buyback program on NASDAQ. At the current market price, the remaining authorization of approximately US$7 million represents the capacity to repurchase roughly 13% of Mogo's outstanding common shares. About Mogo Mogo Inc. (NASDAQ: MOGO; TSX: MOGO) is a financial technology company committed to long-term value creation. We operate across Wealth, Lending, and Payments—each designed to build durable capital, not momentary gain. Through a dual-compounding model that integrates scalable operating growth with a Bitcoin reserve, we serve a rare group: those who value discipline over distraction. Our focus is on helping members build lasting wealth through behavioral investing tools designed to promote patience, clarity, and compounding. Alongside this, our lending products provide convenient access to credit, delivered with the same emphasis on transparency, control, and responsible use. Globally, we operate through Carta Worldwide, enabling modern payments infrastructure for serious fintech and enterprise clients. At Mogo, we build intelligent finance — designed for the long term, and for those who are ready. Forward-Looking Statements This news release may contain 'forward-looking statements' within the meaning of applicable securities legislation, including statements regarding Mogo's Bitcoin treasury strategy and Mogo's capital allocation strategy. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements are typically identified by words such as "may", "will", "could", "would", "anticipate", "believe", "expect", "intend", "potential", "estimate", "budget", "scheduled", "plans", "planned", "forecasts", "goals" and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo's growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, including receipt of applicable regulatory approvals in respect of its products, many of which are outside of Mogo's control. For a description of the risks associated with Mogo's business please refer to the 'Risk Factors' section of Mogo's current annual information form, which is available at and Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
Business Wire
26 minutes ago
- Business Wire
The Nassau Companies of New York Announces Offering of $400 Million Senior Notes
HARTFORD, Conn.--(BUSINESS WIRE)--The Nassau Companies of New York announced today that it has commenced a private offering (the 'Offering') of $400 million aggregate principal amount of its senior notes due 2030 (the '2030 Notes'), subject to market and other conditions. The Nassau Companies of New York intends to use the net proceeds from the offering for general corporate purposes and to repay in full all outstanding amounts under the existing term loan credit facility. The 2030 Notes are being offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the 'Securities Act'), and to certain non-U.S. persons in transactions outside the United States in compliance with Regulation S under the Securities Act. The offer and sale of the 2030 Notes have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This release does not constitute an offer to sell or the solicitation of an offer to buy the 2030 Notes, nor will there be any sale of the 2030 Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. About The Nassau Companies of New York The Nassau Companies of New York, a Delaware corporation, is a subsidiary of Nassau Financial Group ('Nassau'). Based in Hartford, Conn., Nassau is a growth-focused and digitally enabled financial services company with an integrated platform spanning insurance and asset management. Forward-Looking Statements This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 ('PSLRA') and the federal securities laws. All statements herein, other statements of historical fact, are forward-looking and intended to be covered by the safe harbor for 'forward-looking statements' provided by the PSLRA. Without limiting the foregoing, statements including the words 'will,' 'expects,' 'believes,' 'anticipates,' 'includes,' 'plans,' 'assumes,' 'estimates,' 'projects,' 'intends,' 'should,' 'would,' 'could,' 'may,' 'might,' 'potential,' 'target' and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in the forward-looking statements, including, among others: the results of operations of Nassau Insurance Company, Nassau Life and Annuity Company and Nassau Life Insurance Company of Kansas (the 'Insurance Subsidiaries') are materially affected by economic and political conditions in the U.S. and elsewhere; we are exposed to significant financial and capital risk, including changing interest rates and credit spreads, which may have an adverse effect on our investment portfolio, profitability and financial condition; our businesses remain subject to an uncertain economic, social and political environment; we may have difficulty selling certain holdings in our investment portfolio in a timely manner and realizing full value given their illiquid nature; we could be forced to sell investments at a loss to cover policyholder withdrawals; our investments linked to real estate are subject to credit, market and servicing risk, which could diminish the value of such investments; our investment portfolio may include investments in securities of issuers based outside the U.S., including emerging markets, which may be riskier than securities of U.S. issuers; our valuation of investments may reflect methodologies, estimates and assumptions which are subject to differing interpretations and could result in changes to investment valuations, which may adversely affect our results of operations and financial condition; the determination of the amount of allowances and impairments taken on our investments and our assumptions regarding the fair value and performance of our investments are highly subjective and could materially affect our business, financial condition and results of operations; actual or perceived changes in the global capital markets, general economic and political conditions and policies and interest rates may materially adversely affect our ability to meet liquidity needs, our access to capital, cost of capital, business and results of operations; high inflation levels could have adverse consequences for us, the insurance industry and the U.S. economy generally; we have significant liabilities for policyholders' benefits which are subject to insurance risk; we are a party to numerous transactions with related parties, which a prospective investor should consider; the interests of our controlling owners may be different from or even adverse to those of the holders of the 2030 Notes ('Noteholders'), and they have no duty to act in the best interests of Noteholders; the indenture governing the 2030 Notes (the 'Indenture') does not limit their control over us; our results of operations and financial condition depend on the accuracy of a broad range of assumptions and estimates made by our management; guaranteed benefits within our Insurance Subsidiaries' products may have an adverse effect on our earnings; if our risk management policies and procedures, which include the use of derivatives and reinsurance, are not adequate to protect us, we may be exposed to unidentified, unanticipated or inadequately managed risks; our insurance and reinsurance products depend on assumptions related to mortality, morbidity, lapsation, investment returns and expenses, and significant deviations in experience could negatively affect their financial condition and results of operations; our reinsurance program involves risks because we remain liable with respect to the liabilities ceded to reinsurers if the reinsurers fail to meet the obligations assumed by them; there is no guarantee that we will be able to obtain reinsurance on favorable terms and at favorable rates in the future; our failure to comply with the terms of our current or future credit facilities or agreements, the indenture for NCNY's $300 million aggregate principal amount of 7.45% senior unsecured notes due 2032, the indenture for NNY's $175 million aggregate principal amount of 7.15% surplus notes due 2034 or the Indenture, or our undergoing a change of control could trigger prepayment obligations or other remedies in favor of the holders of our indebtedness or preferred equity, which could materially adversely affect our business, results of operations and financial condition; our repurchase agreements and reverse repurchase agreements subject us to potential liquidity and other risks; our dependence on our membership in the Federal Home Loan Bank of Boston subjects us to potential liquidity and other risks; our Insurance Subsidiaries may require additional capital to support their business and sustained future growth, which may not be available when needed or may be available only on unfavorable terms, and to comply with regulatory developments that may affect capital requirements; new accounting rules or changes to existing accounting rules could negatively impact our Insurance Subsidiaries' businesses; we may experience volatility in generally accepted accounting principles net income primarily because of the application of fair value accounting to our derivative instruments; we estimate gross profits in the course of our business, and if our estimates change significantly, we may be required to expense our deferred policy acquisition costs and value of business acquired in an accelerated manner, which would reduce our profitability; any failure to protect the confidentiality of client information, including as a result of human error or failure in our cybersecurity, could adversely affect our reputation and have a material adverse effect on our business, financial condition and results of operations and other aspects of our business; if we do not manage our growth effectively, our financial performance could be adversely affected; our historical growth rates may not be indicative of our future growth; the loss of key employees could adversely affect our operations; we depend on the performance of our third-party service providers, and their failure to perform in a satisfactory manner could adversely affect our business; we face competition from companies that have greater financial resources, broader arrays of products, higher ratings and stronger financial performance, which may impair our ability to retain existing customers, attract new customers, maintain or expand our distribution sources and maintain our profitability and financial condition; our ability to consummate acquisitions and block reinsurance transactions on economically advantageous terms acceptable to us in the future is unknown; the Insurance Subsidiaries may not be able to invest in the types of portfolio investments we have contemplated and, therefore, may be unable to generate the returns we currently expect; artificial intelligence could increase competitive, operational, legal and regulatory risk to our business in ways that we cannot predict; if we are unable to attract and retain national marketing organizations, sales of our products may be reduced; our products and services are sold through intermediaries, and the misrepresentation of our products or services or a failure to properly perform services or the misrepresentation of our products or services could have an adverse effect on our revenues and income and could expose us to liability or litigation; controls and business continuity plans surrounding our information technology could fail or security could be compromised, which could damage our business and adversely affect our financial condition and results of operations; employee and agent error and misconduct may be difficult to detect and prevent and may result in significant losses; the Insurance Subsidiaries' business operations depend on their abilities to appropriately distribute, execute and administer their policies and claims; the Insurance Subsidiaries must find ways to maintain effective control over growing expenses; a pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide, and its variants, could adversely affect our business, investments and financial condition; catastrophic event risks such as terrorist attacks, floods, severe storms or hurricanes or computer cyber-terrorism could have a material adverse effect on our business; a downgrade or potential downgrade in our Insurance Subsidiaries' credit or financial strength ratings could harm our competitive position; financial services companies are frequently the targets of litigation, including class action litigation, which could result in substantial defense costs, settlements and judgments; changes in state and federal regulation, including new capital requirements, may affect our financial condition, liquidity and results of operations and other aspects of our business in ways that we cannot predict; PHL Variable Insurance Company, one of our former subsidiaries, is involved in an ongoing rehabilitation, which could adversely affect our reputation, business, financial condition and results of operations; we face a risk of noncompliance with and enforcement action under anti-money laundering statutes and regulations; state treasury and insurance department initiatives with respect to unclaimed property may result in liabilities for our Insurance Subsidiaries if we or our reinsurers are not compliant; our business may be adversely affected by adverse publicity or increased governmental and regulatory actions with respect to us, other companies or the financial services industry in general; the financial services industry faces great uncertainty from a regulatory perspective; risks from various National Association of Insurance Commissioners initiatives could impact profitability and capital; the Insurance Subsidiaries may face increased scrutiny from their local regulators; the Insurance Subsidiaries may face regulatory constraints on the amount, if any, of dividends permitted to be paid to Nassau; the impact of potential legislation limiting cessions by onshore insurers to offshore affiliated reinsurers or the imposition of greater tax burdens on such cessions; regulatory constraints on intercompany transactions; possible regulatory approval constraints on the development of new products; changes in federal income taxation laws, including reduction in individual income tax rates or modification to BEAT, may adversely affect sales of our Insurance Subsidiaries' products and profitability; our ability to use our net operating losses to offset future taxable income may be subject to certain limitations; our substantial level of indebtedness could adversely affect our financial condition and prevent us from making payments on the 2030 Notes and our other debt obligations; if we do not generate sufficient cash flows, we may be unable to service all of our indebtedness; we are a holding company and depend on our subsidiaries to generate sufficient cash flow to meet our debt service obligations, including payments on the 2030 Notes; the 2030 Notes will be unsecured and will be effectively subordinated to any secured indebtedness we incur; claims of holders of the 2030 Notes will be structurally subordinated to claims of creditors of certain of our subsidiaries that will not guarantee the 2030 Notes; the guarantees by Nassau, Nassau Insurance Group Holdings, L.P., The Nassau Companies, Nassau Asset Management LLC, and NRH, L.P., jointly and severally, on a senior unsecured basis pursuant to the Indenture (the 'Note Guarantees') may not be enforceable (or could be voidable) because of fraudulent transfer or conveyance laws and, as a result, you may be required to return payments received by you in respect of the Note Guarantees; our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly; we may not be able to satisfy our obligations to holders of the 2030 Notes upon a change of control; the 2030 Notes do not restrict our ability to incur additional debt or prohibit us from taking other action that could negatively impact holders of the 2030 Notes; if the 2030 Notes become rated investment grade by each of S&P Global Ratings and Moody's Investors Service, Inc., certain covenants will not be applicable and the Note Guarantees may be released; the Indenture will contain cross-default or cross-acceleration provisions that may cause all of the 2030 Notes to become immediately due and payable because of a default under an unrelated debt instrument; the Indenture and the terms of our other indebtedness will impose significant operating and financial restrictions, which may prevent us from capitalizing on business opportunities and may impede our ability to refinance our indebtedness; we may designate certain of our subsidiaries as unrestricted, in which case they would not be subject to the restrictive covenants in the Indenture; there is no public market for the 2030 Notes, and you cannot be sure that an active trading market will develop for them; The Nassau Companies of New York may redeem the 2030 Notes prior to the maturity date, and you may not be able to reinvest in a comparable security; the credit ratings assigned to The Nassau Companies of New York, Nassau and to the 2030 Notes may not reflect all risks of an investment in the 2030 Notes, and an adverse rating of the 2030 Notes may cause their trading price to decline; an increase in market interest rates could result in a decrease in the value of the 2030 Notes; we are not providing all of the information that would be required if this Offering were being registered with the Securities and Exchange Commission; we may be unable to repay or repurchase the 2030 Notes at maturity; and our shareholders' interests may conflict with yours as a Noteholder. The foregoing summary of important factors is not exhaustive. The forward-looking statements should be considered in light of these risks and uncertainties. All forward-looking statements in this release are based solely on information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Please refer to the 'Risk Factors' section of the Offering Circular for a discussion of important factors that should be considered before investing in the 2030 Notes.
Business Insider
34 minutes ago
- Business Insider
Tesla CEO vs. Trump: Elon Musk's Political Gambit Sparks ‘Train Wreck' Remark
Tesla (TSLA) CEO Elon Musk has reignited political drama—this time not over markets, but politics. Over the weekend, Musk officially launched a new U.S. political party called the 'America Party,' saying it was needed to break the current 'one-party system' and restore 'freedom' to Americans. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. The announcement didn't go unnoticed. President Donald Trump sharply criticized Musk's move, calling him a 'train wreck' and claiming he had gone 'completely off the rails' in recent weeks. Trump also took aim at the viability of third parties in U.S. politics, calling the idea 'ridiculous' and a source of 'confusion.' Musk Breaks with Trump in Political Power Play The feud marks a sharp turn in their relationship. Musk had previously donated over $250 million to Trump's campaign and briefly served as an adviser in the White House, leading a cost-cutting initiative known as 'Doge.' But tensions rose after Musk criticized Trump's recently signed 'One Big Beautiful Bill Act,' warning that it would add $3 trillion to the national debt and 'bankrupt' the country. Musk Launches Party, Raises New Risks While Musk hasn't confirmed any personal political run, he hinted that the America Party may focus on select congressional races in 2026, sparking speculation about its potential to draw votes away from Republicans in key districts. Adding to the drama, Treasury Secretary Scott Bessent suggested that Musk's political involvement might worry Tesla and SpaceX's boards. Musk fired back, calling Bessent a 'Soros stooge' due to his past ties with Soros Fund Management, where he helped manage large investments under financier George Soros. With politics entering Musk's already packed portfolio, both Wall Street and Washington are watching closely, especially as Tesla gears up for its Q2 earnings later this month. What Is the Prediction for Tesla Stock? When it comes to Elon Musk's companies, most of them are privately held. However, retail investors can invest in his most popular company, Tesla. Turning to Wall Street, analysts have a Hold consensus rating on TSLA stock based on 14 Buys, 12 Holds, and nine Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average TSLA price target of $293.09 per share implies 7.06% downside risk.
